Medical Xpress news
Medical Xpress / Distinct tumor 'neighborhoods' could guide more targeted treatments in aggressive childhood brain cancer
New research published in Nature finds that tumor cells within supratentorial ependymomas (SE)—an aggressive childhood brain cancer—cluster into distinct tumor cell populations. Much like a neighborhood, each cell subtype ...
Medical Xpress / Three-year study tracks early Parkinson's decline using wearables and patient reports
A new study in the Journal of Neurology offers critical longitudinal insights into how symptoms and functional impacts evolve for individuals with early Parkinson's disease (PD). Led by Jamie Adams, M.D. and Jennifer Mammen, ...
Medical Xpress / Mothers' exposure to microbes protects their newborn babies against infection
A multi-center study led by researchers at Cincinnati Children's sheds new light on why some newborns become severely ill from Escherichia coli infection, but others do not. It turns out that most babies are immune because ...
Medical Xpress / Foreign aid cuts to tuberculosis services could cost families $80 billion worldwide
More than a year after the second Trump administration began dismantling the US Agency for International Development (USAID), the global health consequences of this unprecedented loss in international aid continue to surface. ...
Medical Xpress / How one flu virus can hamper the immune response to another
Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell ...
Medical Xpress / Claims data study ties epilepsy drugs in pregnancy to developmental risks
Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and indicate no substantial risk ...
Medical Xpress / Safer blood clot treatment: Apixaban beats rivaroxaban in head-to-head comparison
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, ...
Medical Xpress / Study finds ALS drug hope via AI and veteran records
A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified several existing medications ...
Medical Xpress / A workout playlist for your heart? Why musical structure could guide rehab
New findings on how the human heart adapts to expressive music features, like loudness or tempo, could lay the foundations for targeted music-based "exercises" to support heart health. Led by King's College London, the study ...
Medical Xpress / Clarifying how ketogenic diets treat epilepsy to guide future therapy development
Published in The Lancet Neurology, a new review from the University of Colorado Anschutz in collaboration with UT Southwestern Medical Center, offers the latest scientific explanations for why ketogenic diets reduce seizures ...
Medical Xpress / A new tool to predict physical health risks in young people with psychosis
A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes.
Medical Xpress / Dengue vaccine remains 80.5% effective against severe cases after five years
In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a five-year period. The results ...
